Ardelyx Inc. sell Lokrim
Start price
26.07.21
/
10%
€1.32
Target price
26.07.22
-
Performance (%)
-48.82%
End price
27.07.22
€0.68
Summary
This prediction ended on 27.07.22 with a price of €0.68. Lokrim correctly predicted massive losses of -48.82% for Ardelyx Inc.. Lokrim has 10% into this prediction This prediction was marked as speculative and is excluded from Lokrim's performance statistics.Ardelyx, Inc. is a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medicines aimed at treating kidney and cardiovascular diseases. The company uses a unique approach to drug discovery, developing therapeutics that target ion channels and transporters, which play a critical role in regulating activities in the body. Ardelyx's lead product candidate, tenapanor, is being studied for the treatment of conditions such as hyperphosphatemia in patients with chronic kidney disease, irritable bowel syndrome with constipation, and diverticulosis. The company is listed on the NASDAQ exchange under the ticker symbol ARDX.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ardelyx Inc. | -0.366% | -0.366% | 47.951% |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% |
According to Lokrim what are the pros and cons of Ardelyx Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Lokrim for this prediction
In the thread Ardelyx Inc. diskutieren
Sell Ardelyx Inc.
In the thread Trading Ardelyx Inc.
Die von Lokrim gewählte maximale Laufzeit wurde überschritten